www.fdanews.com/articles/88209-alnylam-pharma-amends-rnai-agreements-with-merck
ALNYLAM PHARMA AMENDS RNAI AGREEMENTS WITH MERCK
July 10, 2006
Alnylam Pharmaceuticals, a biopharmaceutical company developing novel therapeutics based on RNA interference, has amended its two existing RNAi collaboration agreements with Merck and consolidated the efforts into a single ongoing collaboration.
Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34162§ionid=)